Disease Library/Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies/Advocacy Hub

Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database
💊
1FDA treatments
🩺
2Specialists
💰
1Open funds

Regulatory Watchboard

2 events
Sep 2025Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

National and Kapodistrian University of Athens

TrialNOT YET RECRUITING
Aug 2020Enspryng: FDA approved

treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Enspryng

Genentech, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Enspryng

(SATRALIZUMAB)Orphan drug

Genentech, Inc.

12.1 Mechanism of Action The precise mechanism by which satralizumab-mwge exerts therapeutic effects in NMOSD is unknown but is presumed to involve in...

Approved Aug 2020FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies.
Search all trials →
Search clinical trials for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies →

Recent News & Research

No recent news articles indexed yet for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies.
Search PubMed for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies →

Browse all Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies news →

Specialist Network

Top 2 by expertise
XC

Xiangjun Chen, M.D

Huashan Hospital

Score 151 trial
PL

Pablo Lopez

Hospital Aleman

Score 151 trial21 pubs

View all Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰

Latest News

Research, approvals & updates

📚

Browse All Diseases

11,000+ rare disease profiles